Healthcare -
Biotechnology - NASDAQ - US
$ 18.01
0.671 %
$ 1.24 B
Market Cap
-3.76
P/E
ARVN - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ARVN - Arvinas, Inc.
375 M
LAST VALUE
15.97%
2 YEAR CAGR
17.39%
5 YEAR CAGR
0.00%
10 YEAR CAGR